CBD is fast becoming a popular medicine for a variety of symptoms. Pharmaceutical industry requires a higher grade of cannabidiol than supplement or other customers.

Cosmetics, beauty and makeup benefit from CBD for skin care. This is estimated at 1.1 billion dollars in USA by 2025 (Cowen and Company)

The world’s most recognisable soft drink and beer companies have been preparing to launch CBD products, waiting for stable consistent supply. This is estimated at 2.4 billion dollars in USA by 2025 (Cowen and Company)

Nutraceuticals and Supplements containing CBD are becoming a standard item on pharmacy shelves and health shops globally, this is thought to be a 6.4billion dollar industry in USA alone by 2025. (Cowan and Company)

Topicals are gaining popularity, because they work in skin, through skin and in jurisdictions where CBD can't be taken internally.

Big tobacco are expected to add CBD vape as a standard item to their product ranges. BioPharm’s product provides on demand scalable product with out plant based impurities or contamination. This is estimated at 1 billion dollars in USA by 2025 (Cowen and Company)

Food and edible items are popular in USA and poised to launch as CBD undergoes application as a novel food in EU market. This is estimated at 1.1 billion dollars in USA by 2025 (Cowen and Company)

CBD is fast becoming a popular medicine for a variety of symptoms. Pharmaceutical industry requires a higher grade of cannabidiol than supplement or other customers.

Cosmetics, beauty and makeup benefit from CBD for skin care. This is estimated at 1.1 billion dollars in USA by 2025 (Cowen and Company)

The world’s most recognisable soft drink and beer companies have been preparing to launch CBD products, waiting for stable consistent supply. This is estimated at 2.4 billion dollars in USA by 2025 (Cowen and Company)

Nutraceuticals and Supplements containing CBD are becoming a standard item on pharmacy shelves and health shops globally, this is thought to be a 6.4billion dollar industry in USA alone by 2025. (Cowan and Company)

Topicals are gaining popularity, because they work in skin, through skin and in jurisdictions where CBD can't be taken internally.

Big tobacco are expected to add CBD vape as a standard item to their product ranges. BioPharm’s product provides on demand scalable product with out plant based impurities or contamination. This is estimated at 1 billion dollars in USA by 2025 (Cowen and Company)

Food and edible items are popular in USA and poised to launch as CBD undergoes application as a novel food in EU market. This is estimated at 1.1 billion dollars in USA by 2025 (Cowen and Company)